Sensei Biotherapeutics In...

NASDAQ: SNSE · Real-Time Price · USD
8.68
1.18 (15.73%)
At close: Aug 15, 2025, 3:59 PM
8.80
1.38%
After-hours: Aug 15, 2025, 07:56 PM EDT

Sensei Biotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
9.99M 13.01M 17.8M 7.16M
Short-Term Investments
31.34M 52.75M 89.32M 140.46M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
48K 86K 63K 39K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
120K 325K 344K 374K
Total Current Assets
41.93M 67.25M 108.59M 148.54M
Property-Plant & Equipment
3.38M 7.04M 9.72M 4.64M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
3.43M 7.12M 9.79M 4.68M
Total Assets
45.36M 74.37M 118.38M 153.22M
Account Payables
n/a 1.69M 4.47M 2.46M
Deferred Revenue
n/a n/a -4.47M n/a
Short-Term Debt
2.32M n/a 2.13M 680K
Other Current Liabilities
3.13M n/a 331K 1.07M
Total Current Liabilities
5.45M 5.64M 9.07M 4.89M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 67K n/a 149K
Total Long-Term Liabilities
1.53M 3.84M 5.9M 1.82M
Total Liabilities
6.97M 9.48M 14.97M 6.71M
Total Debt
3.85M 6.21M 8.03M 2.35M
Common Stock
3K 3K 3K 3K
Retained Earnings
-262.05M -231.9M -197.79M -149.21M
Comprehensive Income
-13K -209K -1M -333K
Shareholders Equity
38.39M 64.89M 103.41M 146.51M
Total Investments
31.34M 52.75M 89.32M 140.46M